Mark R. Brunswick
General Counsel bei SORRENTO THERAPEUTICS, INC.
Profil
Mark R.
Brunswick is currently the Senior Vice President of Regulatory Affairs & Quality at Sorrento Therapeutics, Inc. He previously worked as the Director of Regulatory Affairs at Elan Biopharmaceuticals, Inc. and as the Head of Regulatory Affairs at Arena Pharmaceuticals, Inc. From 2011 to 2016, he was the Head of Regulatory Affairs & Quality at Sophiris Bio, Inc. Brunswick holds a doctorate degree from University College London.
Aktive Positionen von Mark R. Brunswick
| Unternehmen | Position | Beginn |
|---|---|---|
| SORRENTO THERAPEUTICS, INC. | General Counsel | 01.01.2017 |
Ehemalige bekannte Positionen von Mark R. Brunswick
| Unternehmen | Position | Ende |
|---|---|---|
| SOPHIRIS BIO | General Counsel | 01.05.2016 |
| ARENA PHARMACEUTICALS | General Counsel | - |
Elan Biopharmaceuticals, Inc.
 Elan Biopharmaceuticals, Inc. Medical DistributorsDistribution Services Elan Biopharmaceuticals, Inc. distributes drugs and pharmaceuticals. It currently distributes three concentrated morphine sulfate oral solutions which include RoxanolT CII, Roxanol-TT CII and Roxanol 100T CII. Elan Biopharmaceuticals is located in San Diego, CA. | General Counsel | - |
Ausbildung von Mark R. Brunswick
| University College London | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
Sophiris Bio, Inc.
 Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The company was founded by James L. Heppell in May 2003 and is headquartered in La Jolla, CA. | Health Technology |
Elan Biopharmaceuticals, Inc.
Elan Biopharmaceuticals, Inc. Medical DistributorsDistribution Services Elan Biopharmaceuticals, Inc. distributes drugs and pharmaceuticals. It currently distributes three concentrated morphine sulfate oral solutions which include RoxanolT CII, Roxanol-TT CII and Roxanol 100T CII. Elan Biopharmaceuticals is located in San Diego, CA. | Distribution Services |
